CHMMF vs JNJ: Which Stock is Better?
Side-by-side comparison of Chimeric Therapeutics Limited and Johnson & Johnson in 2026
CHMMF
Chimeric Therapeutics Limited
$0.00
JNJ
Johnson & Johnson
$234.18
Key Metrics Comparison
| Metric | CHMMF | JNJ | Winner |
|---|---|---|---|
| Market Cap | $4.42M | $564.35B | JNJ |
| P/E Ratio | N/A | 21.23 | JNJ |
| EPS (TTM) | $N/A | $11.03 | JNJ |
| Revenue Growth | -0.5% | 0.1% | JNJ |
| Gross Margin | 91.3% | 68.0% | CHMMF |
Analyze CHMMF
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHMMF or JNJ a better investment?
Comparing CHMMF and JNJ: Chimeric Therapeutics Limited has a market cap of $4.42M while Johnson & Johnson has $564.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHMMF and JNJ?
CHMMF (Chimeric Therapeutics Limited) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHMMF or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHMMF or JNJ?
JNJ has higher revenue growth at 0.1% vs -0.5% for CHMMF.
Which company is more profitable: CHMMF or JNJ?
Chimeric Therapeutics Limited (CHMMF) has higher gross margins at 91.3% compared to 68.0% for JNJ.
Which is the larger company: CHMMF or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $564.35B compared to $4.42M for CHMMF.
Should I buy CHMMF or JNJ in 2026?
Both CHMMF and JNJ have investment merit. CHMMF trades at $0.00 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHMMF and JNJ stock?
Key differences: Market Cap ($4.42M vs $564.35B), P/E Ratio (N/A vs 21.2x), Revenue Growth (-0.5% vs 0.1%), Gross Margin (91.3% vs 68.0%).